# Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)

> **NCT05565352** · — · ENROLLING_BY_INVITATION · sponsor: **Medical University of Gdansk** · enrollment: 140 (estimated)

## Conditions studied

- Major Depressive Disorder
- Post Traumatic Stress Disorder
- Obsessive-Compulsive Disorder
- Somatoform Disorders
- Anxiety Disorders
- Dissociative Disorder

## Interventions

- **DRUG:** Ketamine Hydrochloride

## Key facts

- **NCT ID:** NCT05565352
- **Lead sponsor:** Medical University of Gdansk
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-09-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05565352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05565352, "Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05565352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*